View of CLINICAL SIGNIFICANCE OF VISFATIN AS AN ADIPOCYTOKINE BIOMARKER IN WOMEN WITH OBESITY-ASSOCIATED ENDOMETRIAL PATHOLOGY

Return to Issue Details CLINICAL SIGNIFICANCE OF VISFATIN AS AN ADIPOCYTOKINE BIOMARKER IN WOMEN WITH OBESITY-ASSOCIATED ENDOMETRIAL PATHOLOGY Download Download PDF